热门出版物 - 学术资源搜索

h5 指数:83
h5 中位数:110

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#8 Genetics & Genomics

标题/作者	引用次数	年份
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2. 0): a policy statement of the American College of Medical Genetics and Genomics SS Kalia, K Adelman, SJ Bale, WK Chung, C Eng, JP Evans, GE Herman, ... Genetics in Medicine 19 (2), 249-255	1352	2017
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples R Walsh, KL Thomson, JS Ware, BH Funke, J Woodley, KJ McGuire, ... Genetics in Medicine 19 (2), 192-203	515	2017
Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria K Nykamp, M Anderson, M Powers, J Garcia, B Herrera, YY Ho, ... Genetics in Medicine 19 (10), 1105-1117	422	2017
Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) ER Riggs, EF Andersen, AM Cherry, S Kantarci, H Kearney, A Patel, ... Genetics in Medicine 22 (2), 245-257	395	2020
Prediction of CYP2D6 phenotype from genotype across world populations A Gaedigk, K Sangkuhl, M Whirl-Carrillo, T Klein, JS Leeder Genetics in Medicine 19 (1), 69-76	359	2017
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) KE Caudle, HM Dunnenberger, RR Freimuth, JF Peterson, JD Burlison, ... Genetics in Medicine 19 (2), 215-223	352	2017
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test AC Lionel, G Costain, N Monfared, S Walker, MS Reuter, SM Hosseini, ... Genetics in Medicine 20 (4), 435-443	346	2018
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature K Schwarze, J Buchanan, JC Taylor, S Wordsworth Genetics in Medicine 20 (10), 1122-1130	343	2018
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors A Lee, N Mavaddat, AN Wilcox, AP Cunningham, T Carver, S Hartley, ... Genetics in Medicine 21 (8), 1708-1718	305	2019
Using high-resolution variant frequencies to empower clinical genome interpretation N Whiffin, E Minikel, R Walsh, AH O’Donnell-Luria, K Karczewski, AY Ing, ... Genetics in Medicine 19 (10), 1151-1158	292	2017
β-Thalassemia R Origa Genetics in Medicine 19 (6), 609-619	274	2017
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database M Dominguez-Valentin, JR Sampson, TT Seppälä, SW ten Broeke, ... Genetics in Medicine 22 (1), 15-25	243	2020
Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework SV Tavtigian, MS Greenblatt, SM Harrison, RL Nussbaum, SA Prabhu, ... Genetics in Medicine 20 (9), 1054-1060	233	2018
Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel MA Kelly, C Caleshu, A Morales, J Buchan, Z Wolf, SM Harrison, S Cook, ... Genetics in Medicine 20 (3), 351-359	223	2018
False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care S Tandy-Connor, J Guiltinan, K Krempely, H LaDuca, P Reineke, ... Genetics in Medicine 20 (12), 1515-1521	217	2018
Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders CF Wright, JF McRae, S Clayton, G Gallone, S Aitken, TW FitzGerald, ... Genetics in Medicine 20 (10), 1216-1223	216	2018
Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders S Srivastava, JA Love-Nichols, KA Dies, DH Ledbetter, CL Martin, ... Genetics in Medicine 21 (11), 2413-2421	213	2019
Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers AM Wenger, H Guturu, JA Bernstein, G Bejerano Genetics in Medicine 19 (2), 209-214	208	2017
The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues PL Sankar, LS Parker Genetics in Medicine 19 (7), 743-750	204	2017
A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology LELM Vissers, KJM van Nimwegen, JH Schieving, EJ Kamsteeg, ... Genetics in Medicine 19 (9), 1055-1063	184	2017

1 - 20

计算机程序会自动估算并确定日期和引用次数。